A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery-Reference-Cited by-同舟云学术

A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery

Published:2006-03 Issue:3 Volume:46 Page:327-338
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Karkouti Keyvan,Beattie W. Scott,Dattilo Kathleen M.,McCluskey Stuart A.,Ghannam Mohammed,Hamdy Ahmed,Wijeysundera Duminda N.,Fedorko Ludwik,Yau Terrence M.

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2006.00724.x/fullpdf

Reference26 articles.

1. Hemostatic Drugs

2. Effect of tranexamic acid on platelet ADP during extracorporeal circulation

3. 3. RC Landis, DO Haskard, and KM Taylor . New antiinflammatory and platelet-preserving effects of aprotinin . Ann Thorac Surg2001 : S1808 -13 .

4. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques

5. Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of ϵ-aminocaproic acid and aprotinin

Cited by 294 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of fibrinolysis inhibitors in cardiac surgery with cardiopulmonary bypass (literature review);Messenger of ANESTHESIOLOGY AND RESUSCITATION;2024-08-26

2. Cost analysis study comparing the impact of treatment with aprotinin versus tranexamic acid in cardiac surgery under cardiopulmonary bypass;Annales Pharmaceutiques Françaises;2024-07

3. Lack of efficacy of aprotinin over tranexamic acid in type A aortic dissection repair;Transfusion;2024-04-06

4. Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management;Hematology, Transfusion and Cell Therapy;2024-04

5. Chemical Adjustment of Fibrinolysis;Pharmaceuticals;2024-01-10